These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Topical opioids for painful ulcers in systemic sclerosis. van Ingen IL; Jansen MM; Barrera P Ann Rheum Dis; 2008 Mar; 67(3):427. PubMed ID: 18292105 [No Abstract] [Full Text] [Related]
5. Multiple sclerosis and systemic sclerosis: efficacy of interferon beta on skin lesions. Carrieri PB; Petracca M; Montella S; Delfino M; Sepe C; Gattoni A Ann Rheum Dis; 2008 Aug; 67(8):1192-3. PubMed ID: 18621969 [No Abstract] [Full Text] [Related]
6. Successful treatment of leg ulcer caused by cryofibrinogenemia by using a systemic corticosteroid and warfarin. Sakieda K; Sumikawa Y; Imaoka K; Murata S; Nakamura C; Mizumoto K; Niihara H; Takagaki K; Morita E Int J Dermatol; 2011 Dec; 50(12):1538-41. PubMed ID: 22098003 [No Abstract] [Full Text] [Related]
7. Basic fibroblast growth factor treatment for skin ulcerations in scleroderma. Yamanaka K; Inaba T; Nomura E; Hurwitz D; Jones DA; Hakamada A; Isoda K; Kupper TS; Mizutani H Cutis; 2005 Dec; 76(6):373-6. PubMed ID: 16438426 [TBL] [Abstract][Full Text] [Related]
8. Successful treatment with bosentan of non-digital skin ulcers in severe scleroderma. Ferreira ME; Scheinberg MA Ann Rheum Dis; 2008 Dec; 67(12):1784-5. PubMed ID: 19005155 [No Abstract] [Full Text] [Related]
9. New elastic support for stasis and stasis ulcers of the legs. Myers HL Vasc Dis; 1968 Dec; 5(4):188-93. PubMed ID: 5726088 [No Abstract] [Full Text] [Related]
10. [Sarcoidosis in a patient with systemic sclerosis]. Castillo Palma MJ; Sánchez Román J; Ocaña Medina C; Gavilán Carrasco F; Martín Juan J Med Clin (Barc); 1999 May; 112(15):597-8. PubMed ID: 10365391 [No Abstract] [Full Text] [Related]
11. Efficacy of Bosentan in treatment of refractory sclerodermic bone prominences skin ulcers. Richetta AG; Mattozzi C; Maiani E; D'Epiro S; Cimillio M; Carboni V; Giancristoforo S; Calvieri S Clin Ter; 2008; 159(5):317-9. PubMed ID: 18998033 [TBL] [Abstract][Full Text] [Related]
13. Chronic leg ulceration as the presenting feature of diffuse systemic sclerosis in childhood. Wahezi DM; Ilowite NT; Kenney-Riley KM; Belamarich PF J Pediatr; 2011 Oct; 159(4):698. PubMed ID: 21784448 [No Abstract] [Full Text] [Related]
14. [Treatment of generalized scleroderma with connective tissue inhibitors]. Asboe-Hansen G Ugeskr Laeger; 1976 May; 138(22):1325-9. PubMed ID: 1273949 [No Abstract] [Full Text] [Related]
15. [Clinico-electromyographic studies in scleroderma and dermatomyositis]. Man'kovskii NB; Aleev LS; Kazakevich RL Zh Nevropatol Psikhiatr Im S S Korsakova; 1968; 68(7):978-83. PubMed ID: 4301380 [No Abstract] [Full Text] [Related]
16. [Treatment of scleroderma]. Guillevin L; Ortonne JP Ann Med Interne (Paris); 1983; 134(8):754-65. PubMed ID: 6364917 [No Abstract] [Full Text] [Related]
17. Scleroderma lung: pathogenesis, evaluation, and current therapy. Co HT; Block JA; Sequeira W Am J Ther; 2000 Sep; 7(5):321-4. PubMed ID: 11317180 [TBL] [Abstract][Full Text] [Related]
18. Systemic sclerosis associated with rectal cancer. Case report and a brief review of the literature. Orphanos G; Ardavanis A; Charalambous P; Stavrakakis J; Rigatos G In Vivo; 2008; 22(6):825-9. PubMed ID: 19181015 [TBL] [Abstract][Full Text] [Related]
19. Nifedipine in scleroderma ulcerations. Woo TY; Wong RC; Campbell JP; Goldfarb MT; Voorhees JJ; Callen JP Int J Dermatol; 1984 Dec; 23(10):678-80. PubMed ID: 6526563 [TBL] [Abstract][Full Text] [Related]